v3.26.1
Commitments and Contingencies (Details Narrative) - USD ($)
6 Months Ended
Mar. 19, 2022
Jun. 30, 2026
Dec. 31, 2025
Loss Contingencies [Line Items]      
Commitments and Contingencies    
License Agreement [Member]      
Loss Contingencies [Line Items]      
Sale of royalty percentage 5.50%    
Development cost, percent 50.00%    
Development costs $ 1,250,000    
Commitments and Contingencies   0 $ 0
License Agreement [Member] | Bio Medical [Member]      
Loss Contingencies [Line Items]      
Loss contingency allegations In exchange, the Licensee shall pay the Company a royalty of 5.5% of net sales. Under the terms of the Equivir Agreement, the Company shall reimburse the Licensee for 50% of the development costs provided that the development costs shall not exceed $1,250,000. As of June 30, 2026 and December 31, 2025, a liability of $0 has been recorded in relation to the Equivir License.    
Employment Agreements [Member] | Mr.Heuszels [Member] | First Year [Member]      
Loss Contingencies [Line Items]      
Employment term bonus   150,000  
Accrued bonus   96,000 96,000
Employment Agreements [Member] | Mr.Heuszels [Member] | Second Year [Member]      
Loss Contingencies [Line Items]      
Employment term bonus   100,000  
Accrued bonus   50,000 $ 25,000
Employment Agreements [Member] | Mr.Heuszels [Member] | Third Year [Member]      
Loss Contingencies [Line Items]      
Employment term bonus   $ 100,000